Acquired rResistance of Lung Adenocarcinoma to EGFR-Tyrosine Kinase Inhibitors GEfitinib and Erlotinib
Acquired rResistance of Lung Adenocarcinoma to EGFR-Tyrosine Kinase Inhibitors GEfitinib and Erlotinib
复制标题
肺腺癌对 EGFR 酪氨酸激酶抑制剂 GEfitinib 和 Erlotinib 的获得性耐药
作者：
Yan Xu;Jun Chen;Hongyu Liu;周清华
